Introduction:Basic information about CAS 106133-20-4|Tamsulosin, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Tamsulosin |
|---|
| CAS Number | 106133-20-4 | Molecular Weight | 408.512 |
|---|
| Density | 1.2±0.1 g/cm3 | Boiling Point | 595.5±60.0 °C at 760 mmHg |
|---|
| Molecular Formula | C20H28N2O5S | Melting Point | 226-228ºC |
|---|
| MSDS | / | Flash Point | 313.9±32.9 °C |
|---|
Names
| Name | tamsulosin |
|---|
| Synonym | More Synonyms |
|---|
Tamsulosin BiologicalActivity
| Description | Tamsulosin is a selective α1 receptor antagonist.Target: α1 receptorTamsulosin is a selective α1 receptor antagonist that has preferential selectivity for the α1A receptor in the prostate versus the α1B receptor in the blood vessels. Tamsulosin-treated patients had a 0.30-fold lower risk of developing acute urinary retention compared with control patients. None of the International Continence Society male questionnaire domain scores showed significant changes between the groups [1]. tamsulosin can be recommended for treating men after catheterization for AUR, and can reduce the likelihood of the need for re-catheterization [2]. |
|---|
| Related Catalog | Research Areas >>EndocrinologySignaling Pathways >>GPCR/G Protein >>Adrenergic ReceptorResearch Areas >>Neurological Disease |
|---|
| References | [1]. Jeong, I.G., et al., Impact of tamsulosin on urinary retention following early catheter removal after robot-assisted laparoscopic radical prostatectomy: a prospective randomized controlled trial. Int J Urol, 2014. 21(2): p. 164-8. [2]. Lucas, M.G., T.P. Stephenson, and V. Nargund, Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia. BJU Int, 2005. 95(3): p. 354-7. |
|---|
Chemical & Physical Properties
| Density | 1.2±0.1 g/cm3 |
|---|
| Boiling Point | 595.5±60.0 °C at 760 mmHg |
|---|
| Melting Point | 226-228ºC |
|---|
| Molecular Formula | C20H28N2O5S |
|---|
| Molecular Weight | 408.512 |
|---|
| Flash Point | 313.9±32.9 °C |
|---|
| Exact Mass | 408.171906 |
|---|
| PSA | 108.26000 |
|---|
| LogP | 2.24 |
|---|
| Vapour Pressure | 0.0±1.7 mmHg at 25°C |
|---|
| Index of Refraction | 1.553 |
|---|
| InChIKey | DRHKJLXJIQTDTD-OAHLLOKOSA-N |
|---|
| SMILES | CCOc1ccccc1OCCNC(C)Cc1ccc(OC)c(S(N)(=O)=O)c1 |
|---|
Safety Information
Customs
| HS Code | 2935009090 |
|---|
| Summary | 2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0% |
|---|
Synonyms
| amsulosin |
| Flomax |
| Benzenesulfonamide, 5-[(2R)-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxy- |
| Tamsulosinum |
| 5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide |
| [14C]-Tamsulosin |
| (R)-5-[2-[[2-(2-Ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide |
| Tamsulosine |
| Tamsulosina |
| 5-{(2R)-2-[(2-{[2-(ethyloxy)phenyl]oxy}ethyl)amino]propyl}-2-(methyloxy)benzenesulfonamide |
| Tamsulosin |
| Tamsolusin |
| MFCD00871531 |
| Tamsulosina [INN-Spanish] |
| Tamsulosine [INN-French] |
| (R)-(-)-5-[2-(2-(2-ethoxyphenoxy)ethylamino)propyl]-2-methoxybenzenesulfonamide |
| 5-[(2R)-2-{[2-(2-Ethoxyphenoxy)ethyl]amino}propyl]-2-methoxybenzenesulfonamide |
| Tamsulosinum [INN-Latin] |